Wendy Dixon

(Dr. Wendy Dixon Ph.D.)

Currently holds positions in Incyte Corp, Alkermes Inc, Alkermes Plc and bluebird bio Inc

Positions

Position Company Period
Independent Director Incyte Corp May 21, 2010 -
Independent Director Alkermes Inc Jan. 13, 2011 -
Independent Director Alkermes Plc Sept. 16, 2011 -
Independent Director bluebird bio Inc April 1, 2013 -
Independent Director Voyager Therapeutics Inc Jan. 1, 2017 - June 4, 2020
Independent Chairman of the Board Carisma Therapeutics Inc Dec. 1, 2016 - Feb. 20, 2020
Independent Director Carisma Therapeutics Inc Oct. 22, 2014 - Dec. 1, 2016
Independent Director Orexigen Therapeutics Inc April 20, 2010 - Jan. 8, 2016
Independent Director Ardea Biosciences Inc April 6, 2011 - June 19, 2012
Wendy Dixon's trades of Incyte Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-06-11 2021-06-10
US Alkermes Plc (ALKS)
PS Planned sale
25,000 -37.7%
25.00
USD 625,000 		25,000 -37.7% 25.00 USD 625,000
2020-08-31 2020-08-27
US Incyte Corp (INCY)
S Sale
20,000 -58.4%
94.51
USD 1,890,200 		20,000 -58.4% 94.51 USD 1,890,200
// ... existing code ... // ... rest of the file ...